CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,720,952
- in 8 filings, $195K under 10b5-1 plans
Net −$9,720,952. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −400 | $105.99 | $42K | 28,951 |
| 2025-12-05 | Freeman Chris Chief Commercial Officer | Sale | −2,964 | $106.71 | $316K | 25,987 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Option exercise | +29,382 | $32.86 | $965K | 81,509 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Option exercise | +26,905 | $28.37 | $763K | 108,414 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −8,033 | $101.42 | $815K | 100,381 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −22,891 | $102.11 | $2.3M | 77,490 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −7,567 | $103.26 | $781K | 69,923 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −11,978 | $103.96 | $1.2M | 57,945 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −250 | $105.82 | $26K | 57,695 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −5,568 | $106.68 | $594K | 52,127 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −3,267 | $101.46 | $331K | 48,860 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −8,774 | $102.11 | $896K | 40,086 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −2,533 | $103.24 | $262K | 37,553 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −5,027 | $103.96 | $523K | 32,526 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −3,284 | $106.70 | $350K | 29,242 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Sale | −1,190 | $107.26 | $128K | 28,052 |
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −29,382 | 7,137 | ||
| 2025-12-05 | Bell Michael Brian Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −26,905 | 10,421 | ||
| 2025-12-05 | CLARK IAN T Director | Option exercise | +9,105 | $38.42 | $350K | 18,956 |
| 2025-12-05 | CLARK IAN T Director | Option exercise | +8,803 | $38.01 | $335K | 27,759 |
Page 34 of 42 · 827 trades